Cardiovascular Disease Study
Cardiovascular Disease
Not SpecifiedActive - Enrolling
Key Facts
Indication
Cardiovascular Disease
Phase
Not Specified
Status
Active - Enrolling
Company
About Arizona Research Center
Arizona Research Center is a private, services-oriented clinical research site operating in Phoenix since 2005. It generates revenue by conducting Phase 1-4 clinical trials on behalf of sponsor companies and CROs across multiple therapeutic areas, including orthopedics, cardiovascular, and metabolic diseases. The company actively recruits both patient volunteers and healthy participants, offering compensation, and also seeks to expand its investigator base. Its primary value proposition is providing patient access and reliable clinical trial execution in a key US geographic market.
View full company profileTherapeutic Areas
Other Cardiovascular Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Manocept Diagnostic | Navidea Biopharmaceuticals | Research |
| Undisclosed Therapeutic Program(s) | HeartcoR Solutions | Pre-clinical |
| Ramatroban (KAR101) | KARE Biosciences | Preclinical |
| Undisclosed Cardiovascular Device Program | Transluminal Technologies | Pre-clinical |
| iPSC-CM Cell Therapy | Khloris Biosciences | Research |
| Clinical Trial Integration | Aktiia | Various |
| Cardiovascular Clinical Trials | PanThera Bio | Not Specified |
| Undisclosed | Zecardio Therapeutics | Discovery/Pre-clinical |
| HDL/LDL Regulation | Alpha-1 Biologics | Pre-clinical |
| Cardiovascular Program | Helixomer | Research |
| Undisclosed Cardiovascular Program | inQB8 Medical Technologies | Pre-clinical |
| Undisclosed Cardiovascular Program(s) | Salubris Biotherapeutics | Clinical-stage (phase unspecified) |